- Home
- ADPT vs LTC Comparison
ADPT vs LTC Comparison
Compare ADPT & LTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- LTC
- Stock Information
- Founded
- ADPT 2009
- LTC 1992
- Country
- ADPT United States
- LTC United States
- Employees
- ADPT N/A
- LTC N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- LTC Real Estate Investment Trusts
- Sector
- ADPT Health Care
- LTC Real Estate
- Exchange
- ADPT Nasdaq
- LTC Nasdaq
- Market Cap
- ADPT 1.4B
- LTC 1.6B
- IPO Year
- ADPT 2019
- LTC 1992
- Fundamental
- Price
- ADPT $11.48
- LTC $35.19
- Analyst Decision
- ADPT Strong Buy
- LTC Hold
- Analyst Count
- ADPT 7
- LTC 5
- Target Price
- ADPT $10.57
- LTC $37.80
- AVG Volume (30 Days)
- ADPT 2.2M
- LTC 314.9K
- Earning Date
- ADPT 07-31-2025
- LTC 07-28-2025
- Dividend Yield
- ADPT N/A
- LTC 6.48%
- EPS Growth
- ADPT N/A
- LTC 0.36
- EPS
- ADPT N/A
- LTC 1.93
- Revenue
- ADPT $189,527,000.00
- LTC $202,686,000.00
- Revenue This Year
- ADPT $24.46
- LTC N/A
- Revenue Next Year
- ADPT $20.25
- LTC $11.33
- P/E Ratio
- ADPT N/A
- LTC $18.22
- Revenue Growth
- ADPT 8.61
- LTC 3.98
- 52 Week Low
- ADPT $3.30
- LTC $31.70
- 52 Week High
- ADPT $12.43
- LTC $39.89
- Technical
- Relative Strength Index (RSI)
- ADPT 63.39
- LTC 51.69
- Support Level
- ADPT $11.17
- LTC $34.20
- Resistance Level
- ADPT $12.43
- LTC $35.58
- Average True Range (ATR)
- ADPT 0.59
- LTC 0.59
- MACD
- ADPT 0.03
- LTC -0.01
- Stochastic Oscillator
- ADPT 62.45
- LTC 63.46
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.